Dominari Holdings Inc. Common Stock (DOMH)
Stock · NASDAQ · Health Care
$2.39as of 8/28/2026
Price chart
Open in TradingViewActive signals
About DOMH
Dominari Holdings Inc., through its subsidiaries, engages in wealth management, investment banking, sales and trading, asset management, and insurance activities in the United States. The company offers full-service brokerage services, including exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options, municipal bonds, mutual funds, exchange-traded f…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 36
- Website
- www.dominariholdings.com/
Fundamentals
- 1-day range
- $2.37$2.56
- Market cap
- $58.34M
- P/E (trailing)
- —
- P/E (forward)
- -1.59
- EPS (trailing)
- $-3.00
- Dividend yield
- —
- Beta
- 0.86
- Avg. volume
- 160.4K
- Ex-dividend date
- May 15, 2026
- Dividend pay date
- May 29, 2026
How Dominari Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Apr 15, 2025 · via SEC EDGAR / Finnhub
Dominari Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DOMHDominari Holdings Inc. Common Stock$2.39▼ 4.02%Market cap $58.34MP/E —$2.19$8.4
- CTORCitius Oncology Inc. Common Stock$0.776▼ 1.77%Market cap $58.15MP/E —$0.491$2.25
- BOLDBoundless Bio Inc. Common Stock$2.83▼ 1.05%Market cap $57.73MP/E —$0.9612$3.16
- DWTXDogwood Therapeutics Inc. Common Stock$2.6▲ 12.07%Market cap $57.51MP/E 1.84$1.28$9.5
- XLOXilio Therapeutics Inc. Common Stock$9▼ 0.22%Market cap $59.51MP/E —$6.47$12.74
- ANVSAnnovis Bio Inc. Common Stock$1.72▼ 4.97%Market cap $59.59MP/E —$1.54$5.5
- PMVPPMV Pharmaceuticals Inc. Common Stock$1.22▼ 1.61%Market cap $59.73MP/E —$1.02$1.88
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DOMH Dominari Holdings Inc. Common Stock | $58.34M | — | $2.39 | ▼ 4.02% | $2.19$8.4 |
| CTOR Citius Oncology Inc. Common Stock | $58.15M | — | $0.776 | ▼ 1.77% | $0.491$2.25 |
| BOLD Boundless Bio Inc. Common Stock | $57.73M | — | $2.83 | ▼ 1.05% | $0.9612$3.16 |
| DWTX Dogwood Therapeutics Inc. Common Stock | $57.51M | 1.84 | $2.6 | ▲ 12.07% | $1.28$9.5 |
| XLO Xilio Therapeutics Inc. Common Stock | $59.51M | — | $9 | ▼ 0.22% | $6.47$12.74 |
| ANVS Annovis Bio Inc. Common Stock | $59.59M | — | $1.72 | ▼ 4.97% | $1.54$5.5 |
| PMVP PMV Pharmaceuticals Inc. Common Stock | $59.73M | — | $1.22 | ▼ 1.61% | $1.02$1.88 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Dominari Year to Date Revenue Increases by 14% Over 2025Yahoo · 8/11/2026
- Dominari Holdings Q2 Adj. EPS $(0.21) Down From $1.12 YoY, Sales $16.789M Down From $38.914M YoYbenzinga · 8/11/2026
- Dominari Holdings Q2 Adj. EPS $(0.21) Down From $1.12 YoY, Sales $16.789M Down From $38.914M YoYBenzinga · 8/11/2026
- New America Acquisition I Corp. Announces Leadership Transition; Kyle Wool Appointed Chief Executive OfficerYahoo · 8/5/2026
- Dominari Congratulates Powerus on its Multimillion Dollar Contract for Aerial Drone SystemYahoo · 8/3/2026
Insider Activity
Insider Actions →- Anthony Hayes · July 27, 2026 · Gift250.0K
- Gregory James Blattner · July 1, 2026 · Grant20.0K
- Kyle Haug · July 1, 2026 · Grant20.0K
- Brian Keith Parsley · July 1, 2026 · Grant20.0K
- Christopher Franklin Devall · July 1, 2026 · Grant20.0K
- Tim S. Ledwick · July 1, 2026 · Grant20.0K
- Anthony Hayes · March 4, 2026 · Grant3.00M
- Kyle Michael Wool · March 4, 2026 · Grant3.00M
Institutional Ownership
March 31, 2026
- Total shares held
- 1.59M
- Total value held
- $5.04M
- Institutional holders
- 29
- Unknown536.0K
- Unknown324.7K
- Unknown132.4K
- Unknown127.8K
- Unknown114.2K
- Unknown102.7K
- Unknown50.3K
- Unknown32.1K
- Unknown26.7K
- Unknown25.2K
See the full, filterable feed with live charts on the MarketWall dashboard.